Connolly, M P <br/><br/>
Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.  [electronic resource] 

 -  Digestion  2009 
 - 241-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1421-9867 
<br/><br/><label>Standard No.: </label>10.1159/000235916  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Administration, Rectal<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Colitis, Ulcerative--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Mesalamine--administration & dosage<br/>Middle Aged<br/>Quality of Life<br/>Treatment Outcome<br/>Young Adult